Cargando…
Epigenetic reprogramming promotes the antiviral action of IFNα in HBV-infected cells
Chronic hepatitis B virus (HBV) infections remain a health burden affecting ~250 million people worldwide. Thus far, available interferon-alpha (IFNα)-based therapies have shown unsatisfactory cure rates, and alternative therapeutic molecules are still required. However, their development has been h...
Autores principales: | Gailhouste, Luc, Sudoh, Masayuki, Qin, Xian-Yang, Watashi, Koichi, Wakita, Takaji, Ochiya, Takahiro, Matsuura, Tomokazu, Kojima, Soichi, Furutani, Yutaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170866/ https://www.ncbi.nlm.nih.gov/pubmed/34078875 http://dx.doi.org/10.1038/s41420-021-00515-y |
Ejemplares similares
-
SEB genotyping: SmartAmp-Eprimer binary code genotyping for complex, highly variable targets applied to HBV
por: Delobel, Diane, et al.
Publicado: (2022) -
An interferon-like small chemical compound CDM-3008 suppresses hepatitis B virus through induction of interferon-stimulated genes
por: Furutani, Yutaka, et al.
Publicado: (2019) -
Molecular dissection of HBV evasion from restriction factor tetherin: A new perspective for antiviral cell therapy
por: Miyakawa, Kei, et al.
Publicado: (2015) -
Epigenetic reprogramming using 5-azacytidine promotes an anti-cancer response in pancreatic adenocarcinoma cells
por: Gailhouste, Luc, et al.
Publicado: (2018) -
Epigenetic Reprogramming of Human Hepatoma Cells: A Low-Cost Option for Drug Metabolism Assessment
por: Gailhouste, Luc, et al.
Publicado: (2017)